Acinetobacter News and Research

RSS

Proper exsanguinator and tourniquet use poorly understood

Operating theater personnel have a poor understanding of appropriate exsanguinator and tourniquet use, show research results from a hospital in Ireland.

21 Jun 2012

MountainView Hospital first in Nevada to use Xenex’s room disinfection device

In an ongoing effort to improve patient safety, MountainView Hospital today announced it is the first hospital in Nevada to use Xenex Healthcare Services' innovative germ-zapping room disinfection technology to keep patients even safer from infections.

21 Jun 2012

BioMed Protect’s Sanotracin RTU rapidly and effectively kills C. difficile within 3 minutes

In the United States Clostridium difficile or "C. difficile" is now recognized as one of the most dangerous and fastest growing Healthcare Acquired Infections (HAIs) in existence. Now surpassing even Staphylococcus aureus (MRSA), C. difficile infections tripled between 2000 and 2005.

6 Jun 2012

New photoactive compound eradicates 'Iraqibacter' from wounds and skin infections

Researchers at the University of California, Santa Cruz, have developed a novel approach for eradicating drug-resistant bacteria from wounds and skin infections, using light to trigger the controlled release of nitric oxide. The UCSC team developed a photoactive compound that releases nitric oxide when exposed to light, and loaded it into a porous, biocompatible material that could be applied as a sprayable powder.

31 May 2012

Declining biodiversity may contribute to rise in asthma, allergies

Declining biodiversity may be contributing to the rise of asthma, allergies, and other chronic inflammatory diseases among people living in cities worldwide, a Finnish study suggests. Emerging evidence indicates that commensal microbes inhabiting the skin, airway, and gut protect against inflammatory disorders. However, little is known about the environmental determinants of the microbiome.

8 May 2012

Study identifies norovirus as major cause of all infection outbreaks in U.S. hospitals

Norovirus, a pathogen that often causes food poisoning and gastroenteritis, was responsible for 18.2 percent of all infection outbreaks and 65 percent of ward closures in U.S. hospitals during a two-year period, according to a new study published in the February issue of the American Journal of Infection Control (AJIC), the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

1 Feb 2012

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy.

21 Nov 2011

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

21 Nov 2011

Study finds multidrug-resistant Acinetobacter baumannii in 48% of infected patient rooms

Multidrug-resistant Acinetobacter baumannii (MDR-AB) was found in the environment of 48 percent of the rooms of patients colonized or infected with the pathogen, according to a new study published in the November issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

2 Nov 2011

Residential washing machines may not eliminate hospital-acquired bacteria

Residential washing machines may not always use hot enough water to eliminate dangerous bacteria like methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter, a Gram-negative bacteria, from hospital uniforms, according to a study published in the November issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

4 Oct 2011

Two TGen students receive SRP grants for antibiotic resistance and Alzheimer's research

Two Arizona university graduate students working at the Translational Genomics Research Institute (TGen) have each received $50,000 grants from the Salt River Project.

23 Sep 2011

ASM to honor LA BioMed investigator for A. baumannii infection study

Ashraf Ibrahim, Ph.D., principal investigator at LA BioMed who specializes in infectious diseases, was recently honored by the American Society for Microbiology (ASM) and the ICAAC Program Committee in the area of Therapy and Prevention of Microbial Disease.

14 Sep 2011

Cone Health uses Xenex room disinfection systems to reduce HAI rates and costs

Cone Health today announced a dramatic reduction in healthcare-acquired infection (HAIs) rates after implementing an infection prevention program which includes Xenex room disinfection systems.

25 Aug 2011

Temple University, URMC partner to translate novel medical research into new drugs

The University of Rochester Medical Center (URMC) and Temple University School of Pharmacy have announced a partnership that will help translate novel medical research into new drugs for treating diseases.

19 Aug 2011

Study confirms ability of Tru-D device to decontaminate surfaces in patient rooms

In an original article coauthored by John M. Boyce, MD; Nancy L. Havill, MT; and Brent A. Moore, PhD, "Terminal Decontamination of Patient Rooms Using an Automated Mobile UV Light Unit", the research team from the Hospital of Saint Raphael and the Yale University School of Medicine ". . . demonstrated that an automated, portable UV light device significantly reduced aerobic colony counts on high-touch surfaces in patient rooms.

12 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

Sodexo selects Xenex as preferred partner for disinfection of client facilities

Sodexo Inc., a world leader in healthcare environmental services management, and Xenex Healthcare Services, the world leader in room disinfection systems, today announced Xenex has been selected as Sodexo's preferred partner for disinfection of Sodexo client facilities. Xenex's portable room disinfection system uses pulsed xenon ultraviolet light to destroy all viruses, bacteria and bacterial spores in the patient environment without contact or chemicals.

18 Jul 2011

ASP unveils innovative healthcare environmental infection prevention technology

Sterilization Products (ASP) announced today the launch of an innovative infection prevention technology – GLOSAIR Healthcare Environmental Decontamination – that provides effective, safe and thorough disinfection of hospital rooms and operating suites to reduce the risk of patient contact with infection-causing pathogens.

27 Jun 2011

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced positive top-line results from the recently completed Phase 2 studies of its CXA-201 and CB-183,315 antibiotic pipeline candidates. CXA-201 was studied for the treatment of complicated intra-abdominal infections (cIAI) in adults.

16 Jun 2011

Bacteria that infect cystic fibrosis patients could help combat MRSA

A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.

27 May 2011